In addition, studies have shown that CD44 can stabilize the SLC7A11 subunit on the cell membrane, promote the growth of CRC cells, and increase SLC7A11-dependent protection from reactive oxygen species (ROS), thus enabling cancer cells to escape from oxidative damage [12,13]. Here, SLC7A11 is linked to cancer.